Navigation Links
Misys - Preliminary Results Interview With CEO
Date:7/23/2009

LONDON, July 23 /PRNewswire-FirstCall/ -- Misys, the banking and healthcare software group, reported continued growth despite the turmoil in financial markets.

The group's full year results have been boosted by a market beating performance at its Allscripts/Misys healthcare joint venture in the US.

In a video interview, CEO Mike Lawrie conceded there are some areas of weakness such as the Treasury and Capital Markets business.

"We did not close some of the deals that we had anticipated closing. Fortunately we are getting some of those closed now in this new year."

Mr Lawrie is, however, certain the overall business is well positioned. He said: "We can continue to execute and deliver growth, revenue growth, profit growth, margin expansion, even if the environment does not materially improve."

The full interview and transcript are available now on http://w3.cantos.com/misys. A live analyst presentation will be available at 0900BST with an on-demand replay later in the day.

It's free to view. All you need to do is register at http://www.cantos.com. Cantos.com, the online financial broadcaster, features in-depth interviews, documentaries and webcasts with senior company executives. If you would like to contact us, please email enquiries@cantos.com or phone +44(0)207-936-1333.


'/>"/>
SOURCE Misys plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Allscripts Announces Final Tax Treatment of Special Cash Dividend From the Transactions With Misys plc Completed in October 2008
2. Misys Wins SWIFTReady TSU 2009 Accreditation for Third Year Running
3. Philippine Farmers Bank Turns to Misys to Underpin its Consumer Lending Business
4. Misys Wins Best Trade Processing Product Accolade in European Banking Technology Readers Choice Awards
5. AlBaraka Islamic Bank Builds on a Long-Term Partnership With Misys Selecting Misys Equation and Trade Innovation for its Pakistan Operations
6. iMedica Announces Agreement with Misys
7. CRDB Bases Growth Strategy on Misys BankFusion Platform
8. Banque Centrale Populaire Consolidates Activity Abroad With New Trade Finance Solutions From Misys
9. Misys Announces Preliminary Results for the Year Ended 31 May 2008
10. Alta Bates Medical Group (ABMG) Teams With Illumisys, LLC to Promote Quality of Care to Patients and Increase Adoption and Use of Health Information Technologies.
11. Antitrust Waiting Period Expires on Allscripts-Misys Merger Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
(Date:12/8/2016)... ... 08, 2016 , ... Vida Health, the digital health platform that ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor ... more consumers who are managing chronic conditions or simply want to improve ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
Breaking Medicine Technology: